MX21592A - 1,3-oxazolidin-2-ona. - Google Patents

1,3-oxazolidin-2-ona.

Info

Publication number
MX21592A
MX21592A MX2159290A MX2159290A MX21592A MX 21592 A MX21592 A MX 21592A MX 2159290 A MX2159290 A MX 2159290A MX 2159290 A MX2159290 A MX 2159290A MX 21592 A MX21592 A MX 21592A
Authority
MX
Mexico
Prior art keywords
oxazolidin
ona
Prior art date
Application number
MX2159290A
Other languages
English (en)
Inventor
Mitsuo Masaki
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of MX21592A publication Critical patent/MX21592A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/22Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2159290A 1984-09-28 1990-07-16 1,3-oxazolidin-2-ona. MX21592A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59203624A JPS6183170A (ja) 1984-09-28 1984-09-28 新規な1,3−オキサゾリジン−2−オン誘導体およびその製造法

Publications (1)

Publication Number Publication Date
MX21592A true MX21592A (es) 1994-01-31

Family

ID=16477122

Family Applications (2)

Application Number Title Priority Date Filing Date
MX205493A MX161397A (es) 1984-09-28 1985-05-31 Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona
MX2159290A MX21592A (es) 1984-09-28 1990-07-16 1,3-oxazolidin-2-ona.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX205493A MX161397A (es) 1984-09-28 1985-05-31 Procedimiento para preparar derivados de 1,3 oxazolidin-2-ona

Country Status (27)

Country Link
US (1) US4644063A (es)
JP (1) JPS6183170A (es)
KR (1) KR900004323B1 (es)
AR (1) AR240924A1 (es)
AT (1) AT392069B (es)
AU (1) AU566419B2 (es)
BR (1) BR8502707A (es)
CA (1) CA1252092A (es)
CH (1) CH663207A5 (es)
CS (1) CS273606B2 (es)
DE (1) DE3519261C2 (es)
DK (1) DK165952C (es)
ES (2) ES8800571A1 (es)
FR (1) FR2571052B1 (es)
GB (2) GB8512975D0 (es)
HU (1) HU199132B (es)
IN (1) IN162060B (es)
IT (1) IT1208807B (es)
MX (2) MX161397A (es)
MY (1) MY102081A (es)
NL (1) NL193191C (es)
NZ (1) NZ212143A (es)
PH (1) PH20852A (es)
RO (1) RO91422B (es)
SE (1) SE463100B (es)
SU (2) SU1402263A3 (es)
ZA (1) ZA854001B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6183147A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤
JPH0759570B2 (ja) * 1986-05-06 1995-06-28 三井東圧化学株式会社 2−オキサゾリジノン類の製造方法
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
EP0307141B1 (en) * 1987-09-10 1993-01-13 MERCK SHARP & DOHME LTD. Oxazoles and thiazoles for the treatment of senile dementia
ES2057110T3 (es) * 1988-03-24 1994-10-16 Sankyo Co Utilizacion de isoxazolinonas como farmacos con accion sobre el cerebro.
JPH0314562A (ja) * 1988-04-11 1991-01-23 Nippon Chemiphar Co Ltd 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
ES2121036T3 (es) * 1992-07-14 1998-11-16 Nippon Chemiphar Co Derivados de alquilenodiamina.
JPH09504272A (ja) * 1993-09-15 1997-04-28 メルク シヤープ エンド ドーム リミテツド ドーパミンアンタゴニストとしてのイミダゾロン及びオキサゾロン誘導体
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
US6037354A (en) * 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
WO2014139975A1 (en) 2013-03-14 2014-09-18 Akzo Nobel Chemicals International B.V. Cellulose ether as a drift control agent and rainfastness agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437389A (en) * 1948-03-09 Oxazoeidones and erocesstok
DE1135461B (de) * 1959-05-08 1962-08-30 Knoll Ag Verfahren zur Herstellung von basisch substituierten Phthalimidinen
FR1301267A (fr) * 1961-04-04 1962-08-17 Science Union Et Compagnie Soc Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation
US3131197A (en) * 1963-03-13 1964-04-28 Smith Kline French Lab 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
FR2179582B1 (es) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
RO91422B (ro) 1987-07-02
DE3519261A1 (de) 1986-04-10
HUT39168A (en) 1986-08-28
RO91422A (ro) 1987-06-30
MX161397A (es) 1990-09-20
JPH0469150B2 (es) 1992-11-05
GB2165237B (en) 1987-12-09
KR900004323B1 (ko) 1990-06-22
HU199132B (en) 1990-01-29
ES8802152A1 (es) 1988-04-01
BR8502707A (pt) 1986-05-27
NL193191B (nl) 1998-10-01
CS273606B2 (en) 1991-03-12
NL8501579A (nl) 1986-04-16
GB8513685D0 (en) 1985-07-03
IT8567500A0 (it) 1985-05-30
AU566419B2 (en) 1987-10-22
SE8502525L (sv) 1986-03-29
GB2165237A (en) 1986-04-09
ES8800571A1 (es) 1987-11-01
ES543517A0 (es) 1987-11-01
IN162060B (es) 1988-03-19
AT392069B (de) 1991-01-25
ZA854001B (en) 1986-01-29
PH20852A (en) 1987-05-19
GB8512975D0 (en) 1985-06-26
ES557075A0 (es) 1988-04-01
SE463100B (sv) 1990-10-08
IT1208807B (it) 1989-07-10
AR240924A2 (es) 1991-03-27
CS392785A2 (en) 1990-08-14
DK230185A (da) 1986-03-29
FR2571052A1 (fr) 1986-04-04
SU1431679A3 (ru) 1988-10-15
US4644063A (en) 1987-02-17
DK165952B (da) 1993-02-15
CH663207A5 (fr) 1987-11-30
SU1402263A3 (ru) 1988-06-07
CA1252092A (en) 1989-04-04
SE8502525D0 (sv) 1985-05-22
KR860002502A (ko) 1986-04-26
NZ212143A (en) 1987-11-27
AR240924A1 (es) 1991-03-27
DK230185D0 (da) 1985-05-23
JPS6183170A (ja) 1986-04-26
NL193191C (nl) 1999-02-02
AU4469785A (en) 1986-04-10
DK165952C (da) 1993-07-05
MY102081A (en) 1992-03-31
DE3519261C2 (de) 1997-01-16
FR2571052B1 (fr) 1988-03-04
ATA165685A (de) 1990-07-15

Similar Documents

Publication Publication Date Title
FI853193A0 (fi) Smaertstillande 1,2-benzisotiazol-3 -ylpiperazinderivat.
FI851114L (fi) Lagringsstabila, snabbt soederfallande farmaceutiska aktivaemnespresstycken.
FI850993L (fi) Utryckningsfordon, speciellt tankslaeckningsfordon foer flygfaelt.
FI851937A0 (fi) Utryckningsfordon, saerskilt brandbil.
FI851505A0 (fi) Valsanordning, speciellt foer en kalander.
FI841948A (fi) Kanna, speciellt termoskanna.
FI851383A0 (fi) Polyfosfat innehaollande, flytande tvaettmedelskomposition foer tvaettinraettningar.
MX21592A (es) 1,3-oxazolidin-2-ona.
FI851935A0 (fi) Utryckningsfordon, saosom brandbil.
FI840878A (fi) Ventilations-/vaermevaexlarsystem foer djurskydd, saerskilt broilerhoenshus.
FI852899A0 (fi) Foerfarande foer framstaellning av fenylsubstituerade 2,4,6,8-nonatetraensyror.
FI853686L (fi) Foerfarande foer framstaellning av 2,4 -diklor-5-fluorbensoesyra.
DE3585315D1 (de) 5,6,7,8-tetrafluoranthrachinonderivate.
FI851743A0 (fi) Saekerhetsfoerslutningskork, saerskilt foer flaskor foer farmaceutiskt bruk.
DE3586745D1 (de) 9,11-epoxy-21-hydroxypregnan-derivate.
FI843996A0 (fi) Kluvet braensle-element foer kaernreaktor, isynnerhet foer kokvattenreaktor.
FI851206L (fi) Isoleringskaerl, saerskilt termoskanna.
FI853421L (fi) 7-oxo-4-tia-1-azabicyklo/3,2,0/ hept-2-enderivat.
FI853585A0 (fi) Foerfarande foer framstaellning av aromatiska 1,4-oxazepinoner och -tioner.
FI852372L (fi) Foerfarande foer framstaellning av substituerade 1,3-dioxanderivat.
FI843391A (fi) Foerfarande foer framstaellning av osymmetriska 1,4-dihydropyridin dikarboxylsyraestrar.
FI902521A0 (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 6,6-etylen-15,16-metylen-3-oxo-17a-pregn-4-en-21,17 -karbolaktoner.
FI842639A0 (fi) Acylderivat av 1,4,3,6-dianhydro- hexitol.
IT8419415A0 (it) Composti 5, 6, 7,8-tetraidroimidazopiridinici.
FI842556A0 (fi) Byggning, foeretraedesvis en stoerre hallbyggning.